Content is intended for people aged >18 years only
At Allergan Aesthetics, our purpose is to empower confidence, creating products and technologies that drive the advancement of aesthetic medicine.
At Allergan Aesthetics, an AbbVie company, patient safety is always our first priority and we are dedicated to driving ethical standards across the industry. We know this is a priority for both patients and practitioners, which is why we have developed the 'A-Z of Medical Aesthetics', a public glossary outlining terminology patients may encounter when embarking on an aesthetics treatment journey.
In doing so, we hope to improve patient’s knowledge and enable them to feel more confident about making the right decisions when it comes to their aesthetic treatments.
Download the A-Z Glossary here
From defining general terminology used during consultations and defining different skin conditions, to pin-pointing treatment areas on the face and breaking-down product ingredients, this glossary aims to help individuals navigate the technical language they may come across during their aesthetics journey.
For use prior to consultations with a qualified aesthetics healthcare practitioner, during the treatment process and afterwards, this glossary aims to de-mystify aesthetics treatments by empowering all patients and inspiring confidence.
Curious to learn more?
Click here for the infographic, we need to talk about aesthetics.
If you have any questions please speak to your aesthetics healthcare practitioner who will be able to support you at the beginning and throughout your aesthetics journey.
Reporting of Side Effects (UK). If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/. By reporting side effects, you can help provide more information on the safety of this medicine.
Reporting of Side Effects (Ireland) If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly at https://www.hpra.ie/. By reporting side effects, you can help provide more information on the safety of this medicine.
UK-AGNA-230327 Date of Preparation:- May 2024